Patents Assigned to AMPLIDIAG OY
  • Patent number: 9868995
    Abstract: The present invention provides a PCR based method for detecting chronic gastritis causing bacterium, namely Helicobacter pylori, in a stool sample. The present invention is based on the use of oligonucleotide primers and probes specific to H. pylori 23S rRNA gene.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: January 16, 2018
    Assignee: AMPLIDIAG OY
    Inventors: Juha Kirveskari, Hilpi Rautelin
  • Patent number: 9593381
    Abstract: The present invention relates to a method and kit for detecting carbapenemase resistance genes causing carbapenem resistance in bacteria. The invention provides oligonucleotide primers, which can be used in the detection. The method can be used to detect OXA-48, SME, GIM-1, VIM 1-22, SPM, GES 1-10, KPC 1-7, IMI 1-3/NMC-A, IMP 1-24 within a single reaction and OXA-23 group, OXA-24 group, OXA-51 group with ISabal promoter, OXA-55, OXA-58, OXA-60, OXA-62, CMY 1, -10, -11 SFC-1, NDM-1, and SIM-1 within another single reaction.
    Type: Grant
    Filed: November 15, 2011
    Date of Patent: March 14, 2017
    Assignee: Amplidiag OY
    Inventors: Juha Kirveskari, Suvi Koskela
  • Publication number: 20160017406
    Abstract: The present invention provides a PCR based method for detecting chronic gastritis causing bacterium, namely Helicobacter pylori, in a stool sample. The present invention is based on the use of oligonucleotide primers and probes specific to H. pylori 23S rRNA gene.
    Type: Application
    Filed: December 5, 2013
    Publication date: January 21, 2016
    Applicant: AMPLIDIAG OY
    Inventors: Juha KIRVESKARI, Hilpi RAUTELIN